WeightNameValue
1000 Titel
  • EPAC and PKA allow cAMP dual control over DNA-PK nuclear translocation
1000 Autor/in
  1. Huston, Elaine |
  2. Lynch, Martin J. |
  3. Mohamed, Ahmed |
  4. Collins, Daniel M. |
  5. Hill, Elaine V. |
  6. MacLeod, Ruth |
  7. Krause, Eberhard |
  8. Baillie, George S. |
  9. Houslay, Miles D. |
1000 Erscheinungsjahr 2008
1000 LeibnizOpen
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2008-08-26
1000 Erschienen in
1000 Quellenangabe
  • 105(35): 12791–12796
1000 FRL-Sammlung
1000 Verlagsversion
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2529053/ |
  • https://doi.org/10.1073/pnas.0805167105 |
1000 Ergänzendes Material
  • http://www.pnas.org/content/105/35/12791/suppl/DCSupplemental |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • We identify a compartmentalized signaling system that identifies a functional role for the GTP exchange factor, exchange protein activated by cAMP (EPAC) coupled to Rap2 in the nucleus. In this system, cAMP regulates the nuclear/cytoplasmic trafficking of DNA-dependent protein kinase (DNA-PK), a critical kinase that acts to repair double-stranded breaks (DSBs) in damaged DNA and to phosphorylate the cell survival kinase, PKB/Akt. Intersecting regulatory inputs for cAMP employ EPAC to transduce positive effects, namely the Rap2-dependent nuclear exit and activation of DNA-PK, whereas protein kinase A (PKA) provides the negative input by antagonizing these actions. We identify this as a compartmentalized regulatory system where modulation of cAMP input into the stimulatory, EPAC and inhibitory, PKA intersecting arms is provided by spatially discrete, cAMP degradation systems. The distribution of DNA-PK between nuclear and cytoplasmic compartments can thus potentially be influenced by relative inputs of cAMP signaling through the EPAC and PKA pathways. Through this signaling system EPAC activation can thereby impact on the Ser-473 phosphorylation status of PKB/Akt and the repair of etoposide-induced DSBs.
1000 Sacherschließung
lokal PDE4
lokal PKB
lokal phosphodiesterase
lokal Akt
lokal rolipram
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/creator/SHVzdG9uLCBFbGFpbmU=|https://frl.publisso.de/adhoc/creator/THluY2gsIE1hcnRpbiBKLg==|https://frl.publisso.de/adhoc/creator/TW9oYW1lZCwgQWhtZWQ=|https://frl.publisso.de/adhoc/creator/Q29sbGlucywgRGFuaWVsIE0u|https://frl.publisso.de/adhoc/creator/SGlsbCwgRWxhaW5lIFYu|https://frl.publisso.de/adhoc/creator/TWFjTGVvZCwgUnV0aA==|https://frl.publisso.de/adhoc/creator/S3JhdXNlLCBFYmVyaGFyZA==|https://frl.publisso.de/adhoc/creator/QmFpbGxpZSwgR2VvcmdlIFMu|https://frl.publisso.de/adhoc/creator/SG91c2xheSwgTWlsZXMgRC4=
1000 Label
1000 Förderer
  1. Medical Research Council |
  2. European Union |
  3. Fondation Leducq, Paris |
1000 Fördernummer
  1. G8604010; G0600765; G0400053
  2. 037189
  3. 06VD02
1000 Förderprogramm
  1. -
  2. -
  3. -
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Medical Research Council |
    1000 Förderprogramm -
    1000 Fördernummer G8604010; G0600765; G0400053
  2. 1000 joinedFunding-child
    1000 Förderer European Union |
    1000 Förderprogramm -
    1000 Fördernummer 037189
  3. 1000 joinedFunding-child
    1000 Förderer Fondation Leducq, Paris |
    1000 Förderprogramm -
    1000 Fördernummer 06VD02
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6406499.rdf
1000 Erstellt am 2018-01-25T17:39:12.098+0100
1000 Erstellt von 218
1000 beschreibt frl:6406499
1000 Bearbeitet von 288
1000 Zuletzt bearbeitet Thu Aug 18 07:43:42 CEST 2022
1000 Objekt bearb. Thu Apr 01 09:27:29 CEST 2021
1000 Vgl. frl:6406499
1000 Oai Id
  1. oai:frl.publisso.de:frl:6406499 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source